Success Case: ChemiCare, Bridge4Pharma, and Therapeutic Innovation
30 January 2024
/
From the Bio4Dreams network comes the collaboration between ChemiCare and Bridge4Pharma to enhance the development of innovative therapies.
ChemiCare and Bridge4Pharma have formed a collaboration to enhance the development of innovative therapies already in the pipeline.
ChemiCare is an innovative SME, currently incubated and supported by Bio4Dreams, specializing in the development of drugs for calcium-related diseases, including rare and autoimmune diseases.
Bridge4Pharma, already our partner, is an expert entity in supporting research and development projects and activities, particularly in the diagnostic, therapeutic, and digital device fields.
The collaboration, accompanied by an investment from Bridge4Pharma in ChemiCare, aims to combine resources and expertise to boost the development of innovative therapeutic solutions already in the pipeline.
This close relationship exemplifies how the Bio4Dreams network can facilitate significant connections and mutual support among its members, paving the way for solutions that can truly transform the health and wellness sector.
See ChemiCare’s update on LinkedIn.
Last updates
1 Jul 24
Call4Ideas FVG: award for best innovative idea to BrainDTech and BioChiCa
The innovative ideas proposed by BrainDTech and BioChiCa at the Call4Ideas FVG were selected among the 11 best.
27 Jun 24
Workshop: presentation of support measures for the FVG Life Sciences ecosystem
The event will discuss investments, innovation, and funding for startups and research to support the FVG Life Sciences ecosystem.
26 Jun 24
Partnership with the University of Udine – Department of Medicine (DMED)
In partnership with DMED to promote research and innovation activities and technology transfer, enhancing scientific networks.